INT238636

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.15
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Abstract
Documents 2
Total Number 2
Disease Relevance 1.12
Pain Relevance 1.06

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (Ada) extracellular space (Ada) cell adhesion (Ada)
plasma membrane (Ada) lysosome (Ada) cytoplasm (Ada)
Ada (Mus musculus)
Pain Link Frequency Relevance Heat
Infliximab 35 100.00 Very High Very High Very High
Adalimumab 8 100.00 Very High Very High Very High
adenocard 4 100.00 Very High Very High Very High
Etanercept 31 99.66 Very High Very High Very High
Crohn's disease 14 98.92 Very High Very High Very High
Inflammation 5 74.56 Quite High
Inflammatory stimuli 1 69.92 Quite High
Central nervous system 6 66.76 Quite High
cytokine 3 64.48 Quite High
ischemia 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 22 98.92 Very High Very High Very High
Apoptosis 49 86.72 High High
Thiamine Deficiency 62 75.00 Quite High
INFLAMMATION 6 74.56 Quite High
Death 14 71.96 Quite High
Aging 4 68.56 Quite High
Ileitis 1 62.44 Quite High
Liver Failure 1 22.92 Low Low
Colitis 36 18.88 Low Low
Inflammatory Bowel Disease 3 12.12 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Indeed, studies in Crohn's disease patients were disappointing with ETC 11, whereas the efficacy of IFX and ADA have been well documented.
Regulation (efficacy) of ADA associated with infliximab, crohn's disease, adalimumab, disease and etanercept
1) Confidence 0.15 Published 2008 Journal International Journal of Medical Sciences Section Body Doc Link PMC2452978 Disease Relevance 0.83 Pain Relevance 0.94
The Q/R editing of GluR2 is mediated by adenosine deaminase acting on RNA 2 (ADAR2).
Regulation (acting) of adenosine deaminase associated with adenocard
2) Confidence 0.01 Published 2010 Journal Mol Neurodegener Section Abstract Doc Link PMC3006372 Disease Relevance 0.28 Pain Relevance 0.12

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox